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Abstract
Background: Current management of patients diagnosed with prostate cancer (PCa) is very effective; however, tumor
recurrence with Castrate Resistant Prostate Cancer (CRPC) and subsequent metastasis lead to poor survival outcome,
suggesting that there is a dire need for novel mechanistic understanding of tumor recurrence, which would be critical for
designing novel therapies. The recurrence and the metastasis of PCa are tightly linked with the biology of prostate cancer
stem cells or cancer-initiating cells that is reminiscent of the acquisition of Epithelial to Mesenchymal Transition (EMT)
phenotype. Increasing evidence suggests that EMT-type cells share many biological characteristics with cancer stem-like
cells.
Methodology/Principal Findings: In this study, we found that PCa cells with EMT phenotype displayed stem-like cell
features characterized by increased expression of Sox2, Nanog, Oct4, Lin28B and/or Notch1, consistent with enhanced
clonogenic and sphere (prostasphere)-forming ability and tumorigenecity in mice, which was associated with decreased
expression of miR-200 and/or let-7 family. Reversal of EMT by re-expression of miR-200 inhibited prostasphere-forming
ability of EMT-type cells and reduced the expression of Notch1 and Lin28B. Down-regulation of Lin28B increased let-7
expression, which was consistent with repressed self-renewal capability.
Conclusions/Significance: These results suggest that miR-200 played a pivotal role in linking the characteristics of cancer
stem-like cells with EMT-like cell signatures in PCa. Selective elimination of cancer stem-like cells by reversing the EMT
phenotype to Mesenchymal-Epithelial Transition (MET) phenotype using novel agents would be useful for the prevention of
tumor recurrence especially by eliminating those cells that are the ‘‘Root Cause’’ of tumor development and recurrence.
Citation: Kong D, Banerjee S, Ahmad A, Li Y, Wang Z, et al. (2010) Epithelial to Mesenchymal Transition Is Mechanistically Linked with Stem Cell Signatures in
Prostate Cancer Cells. PLoS ONE 5(8): e12445. doi:10.1371/journal.pone.0012445
Editor: Chad Creighton, Baylor College of Medicine, United States of America
Received June 28, 2010; Accepted August 6, 2010; Published August 27, 2010
Copyright:  2010 Kong et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was funded by a grant from the National Cancer Institute, National Institutes of Health (NIH) (5R01CA083695-08 to FHS) (http://
projectreporter.nih.gov/reporter_searchresults.cfm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of
the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: fsarkar@med.wayne.edu
. These authors contributed equally to this work.
Introduction
Emerging evidence suggest that most solid tumors including
prostate cancer (PCa) may arise from cancer stem cells [1]. The
cancer stem cells are cells within a tumor that possess the capacity
of self-renewal and tumor-initiating capacity, and differentiate into
the heterogeneous lineages of cancer cells that comprise in a tumor
mass. These tumor-initiating cells could provide a reservoir for
cells that cause tumor recurrence after therapy. Wang et al. have
shown that the origin of PCa cells is from the differentiated
luminal epithelial stem cells [2]. However, there is a greater degree
of phenotypic heterogeneity of cells in PCa, especially within
metastatic sites. Metastases often include rare cells that are
phenotypically undifferentiated [3], suggesting that metastases-
initiating cells may not be the only cells that are derived from
androgen receptor-positive luminal cells. Although origin of PCa
cells needs to be fully elucidated, a number of mounting evidence
suggest that tumor-initiating cells or cancer stem cells play a
critical role in the progression and recurrence of PCa to castrate
resistant prostate cancer (CRPC) and its subsequent metastasis.
Recent studies have indicated that somatic cells can be
reprogrammed into pluripotent embryonic stem-like cells by co-
expression of pluripotency stem cell markers such as Oct4, Sox2,
Nanog and Lin28 [4,5], which raises the possibility that combined
expression of stem cell-associated factors and special oncogenes
could also induce a undifferentiated state in cancer cells.
Interestingly, cell lines derived from human PCa specimen showed
epithelial phenotype. However, immortalization of these cells by
hTERT showed the expression of pluripotency stem cell markers,
including Oct4, Nonag, and Sox2 [6], which could be associated
with disease progression because over-expression of Oct4, Sox2,
Nanog and c-myc has been found in poorly differentiated tumors
[7]. Jeter et al. have shown that knock-down of Nanog in PCa cells
significantly decreased long-term clonogenic growth and inhibited
tumor growth [8]. Oct4 has also been shown to play important
roles in the progression of PCa [9].
Epithelial to mesenchymal transition (EMT) is a vital process
for morphogenesis during embryonic development, but more
recently it has also been implicated in the conversion of early
stage tumors into invasive malignancies [10]. Progression of most
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epithelial differentiation and by switching toward mesenchymal
phenotype, which is accompanied by increased cell motility and
invasion. Recent studies have demonstrated that EMT plays a
critical role not only in tumor metastasis but also in tumor
recurrence that is believed to be tightly linked with the biology of
cancer stem-like cells or cancer-initiating cells [11–13]. Howev-
er, the mechanisms by which EMT cells generate the stem-like
cells remain to be elucidated. MicroRNAs (miRNAs) are
emerging as master regulators of cell differentiation and involved
in the acquisition of EMT phenotype during tumor progression
[14]. Two evolutionary conserved families, miR-200 and let-7
have been shown to regulate the differentiation processes during
the development. Interestingly, recent studies have also shown
that miR-200 family not only could regulate the processes of
EMT by targeting E-box binding protein ZEB1 and ZEB2 [15]
but was also associated with stem-like cell signatures by
regulating the expression of Bmi1 [16,17]. Let-7 family of
miRNAs has been shown to act as a tumor suppressor through
targeting Ras, high mobility group A2 (HMGA2) and c-myc, and
decreased let-7 expression has been linked with increased
tumorigenicity and poor patient prognosis. More importantly,
Let-7 family members regulate the self-renewal of breast cancer
cells [18], which is associated with stem cell phenotype. Recent
studies have also documented that lin28B could block the
accumulation of mature let-7 [19], which in turn regulates
‘‘stemness’’ by inhibiting self-renewal, the cellular characteristics
of cancer stem-like cells associated with tumor recurrence. The
recurrence of PCa is believed to be strongly linked with the
biology of prostate cancer stem cells or cancer-initiating cells
[11,20,21], while increasing evidence have shown that cells with
EMT induced by different factors are rich source of cancer stem-
like cells [12,13,22,23].
Therefore, it is important to identify which factors could
induce EMT and how the EMT cells could become a resource for
cancer stem-like cells, which further underscores the mechanistic
role of such factors toward the development of novel and targeted
therapies for CRPC. Studies have shown that platelet derived
growth factor (PDGF) signaling contributes to EMT [24,25].
Recently, we and others have shown that PDGF-D could regulate
cancer cell invasion and angiogenesis, which was consistent with
the acquisition of EMT phenotype [26–30]. Interestingly,
increased expression of PDGF-D has also been found in human
PCa [31], suggesting that PDGF-D could play important roles in
the progression of human PCa contributed by EMT-phenotypic
or cancer stem-like cells. In this study, we found that PDGF-D
over-expressing PC3 cells acquired EMT phenotype and shared
stem-like cell features characterized by increased expression of
stem cell markers such as Notch1, Sox2, Nanog, Oct4 and
Lin28B, which was consistent with enhanced clonogenic, prosta-
sphere-forming ability as well as increased tumorigenicity in mice.
Concomitantly, we found ARCaPM cells with EMT phenotype
also shared stem-like cell signatures characterized by increased
expression of transcription factor Notch1 and enhanced clono-
genic, prostasphere-forming ability compared with control cells
(ARCaPE cells) with epithelial phenotype. These EMT-type cells
also showed decreased expression of miR-200 or let-7, and
reversal of EMT by forcing expression of miR-200 significantly
inhibited clonogenic and prostasphere-forming ability, which was
consistent with the inhibition of Notch1 and Lin28B expression.
Moreover, knock-down of Lin28B markedly increased let-7
expression, suggesting that miR-200 and let-7 could act as a
target for the prevention of tumor recurrence and metastasis in
PCa.
Results
Clonogenic ability was increased in PC3 PDGF-D and
ARCaPM cells having EMT phenotype
The results from Western blot analysis and cell morphology as
well as our published data have demonstrated that over-expression
of PDGF-D induced EMT phenotype in PC3 cells [26,28]
(Fig. 1A), which was consistent with higher levels of PDGF-D in
cell lysates and conditioned medium (CM) from PC3 PDGF-D
cells compared with PC3 Neo cells (Fig. S1A and S1B). ARCaPM
cells having mesenchymal morphology showed an increased
expression of mesenchymal markers and decreased expression of
epithelial markers compared to ARCaPE cells with epithelial
phenotype (Fig. 1B). To determine whether cells with EMT
phenotype could have stem-like cell characteristics, we performed
clonogenic assay. We found that clonogenic ability was signifi-
cantly increased in PC3 PDGF-D cells compared with PC3 Neo
cells (Fig. 1C, left panel). Fig. 1C, right panel, further indicated
that PC3 PDGF-D cells showed an 11-fold increase in colony
numbers relative to PC3 Neo cells. ARCaPM cells also displayed
an increased clonogenic capacity showing 3-fold increase in colony
numbers compared to ARCaPE cells (Fig. 1D). Soft agar assay,
also known as anchorage independent growth assay, was
performed. PC3 PDGF-D cells showed dramatic increase in
clonogenic potential compared to PC3 Neo cells (Fig. 1E, left
panel). Fig. 1E, right panel, clearly showed the colony numbers
generated from PC3 Neo and PC3 PDGF-D cells per microscopic
field (40 X). These results demonstrated an increase in clonogenic
ability of EMT cells.
Self-renewal capacity was increased by EMT cells
To further determine whether cells with EMT phenotype could
show stem-like cell characteristics, we tested sphere-forming
(termed as prostasphere) ability of PC3 PDGF-D cells compared
to PC3 Neo as well as ARCaPM cells compared to ARCaPE cells
when grown in suspension cultures, which is an in vitro measure of
stem-like cell characteristics. We found that PC3 PDGF-D cells
showed significantly increased ability to form prostaspheres
relative to PC3 Neo cells (Fig. 2A and 2B). The prostaspheres
from PC3 Neo were less than 100 mm in diameter after 6 days,
while 40% of the prostaspheres from PC3 PDGF-D cells were
100–200 mm, 20% of the prostaspheres from PC3 PDGF-D cells
were greater than 200 mm (Fig. 2C). In order to further confirm
whether the prostaspheres are the progeny of individual cells
rather than the aggregates of multiple cells, the prostaspheres (P1)
were collected and the cells were plated at one cell per well in 96-
well plate with ultra low attachment. After 12 days, we found that
one to two new prostaspheres were generated from single PC3
PDGF-D cells, while only 20% single cells of PC3 Neo generated
new prostaspheres (P2, Fig. 2D). ARCaPM cells also exhibited an
increased prostasphere-forming capacity (Fig. 2E and 2F),
suggesting that cells with EMT phenotype have acquired increased
self-renewal capacity. Based on these results, further mechanistic
experiments were focused using PC3 PDGF-D cells compared to
PC3 Neo cells and compared with ARCaPM and ARCaPE cells
wherever warranted.
Gene expression profiling of stem cell markers in cells
with EMT phenotype
To discover the genes regulating and maintaining the stem cell
phenotype of PC3 PDGF-D cells having EMT signatures, we
performed microarray to determine gene expression profiling of
PC3 PDGF-D cells compared to PC3 Neo cells. We found that
PC3 PDGF-D cells showed dramatic changes in expression of
Stem Cell Feature in EMT Cells
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transcription factors Sox2, Nanog, Oct4 and Lin28B, known to be
sufficient to reprogram mouse or human somatic cells to
undifferentiated, pluripotent stem cells, were found to be
significantly increased in PC3 PDGF-D cells compared to PC3
Neo cells. Concomitantly, downstream targets of these transcrip-
tion factors such as Zic2, Zic3, Sall2 and Sall4 were also
significantly up-regulated (Table S2). To further confirm the
results from microarray gene expression analyses, we have
conducted real time RT-PCR and Western blot analysis of
selected genes. The results from real time RT-PCR showed 2 to
thousand-fold increase in mRNA levels of these transcription
factors and their downstream targets in PC3 PDGF-D cells
(Fig. 3A). Western blot analysis also demonstrated that the protein
expressions of Sox2, Nanog, Stat3, Lin28B and Oct4 were
significantly higher in PC3 PDGF-D cells compared with PC3
Neo cells from passage 10 to passage 20 (Fig. 3B).
Polycomb group proteins are known to be involved in the
regulation of gene repression through chromatin modifications,
which is essential for the maintenance of the embryonic and adult
Figure 1. Cells with EMT signatures displayed increased Clonogenic ability. (A) Photographs of cells were shown: PC3 Neo cells displayed
rounded epithelial cell shape and PC3 PDGF-D cells exhibited a fibroblastic-type phenotype (left panel, original magnification, 200 X). Western blot
analysis showed the expression of transcription repressors associated with EMT, and mesenchymal as well as epithelial markers in PC3 Neo and PC3
PDGF-D cells (right panel, passage 10 to 20). (B) The morphology of ARCaPM and ARCaPE cells was shown (left panel).Western blot analysis indicated
the increased ZEB1, vimentin and Notch1 expression and decreased E-cadherin expression in ARCaPM cells compared with ARCaPE (right panel). (C)
and (D) Photographs of colonies from PC3 Neo and PC3 PDGF-D or ARCaPM and ARCaPE were shown (left panel). The colony numbers were counted
and the data was presented as relative colony numbers of PC3 Neo or ARCaPE designed as 1 (right panel). (E) The colonies grown on soft agar were
photographed (left panel, bar, 200 mm). The colony numbers were counted under a phase contrast microscope. Data was presented as colony
numbers per field (right panel). **, p,0.01 compared to Neo or ARCaPE cells (N: PC3 Neo cells, D: PC3 PDGF-D cells,p10: passage 10, E-cad: E-
cadherin).
doi:10.1371/journal.pone.0012445.g001
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contains Suz12, EZH2, EED and RbAp subunits and functions
in the embryonic and adult stem cells to repress developmental
genes that are preferentially activated during differentiation.
Moreover, further studies have shown that PRC2 target genes
are co-occupied by stem cell regulators such as Oct4, Sox2 and
Nanog [34]. During the data analysis of our microarray data, we
found that the levels of EZH2 and Suz12a mRNA were increased
in PC3 PDGF-D cells compared to PC3 Neo cells (Table S2),
which were further confirmed by real time RT-PCR (Fig. 3C). In
addition, the protein levels of EZH2 was significantly up-regulated
in PC3 PDGF-D cells relative to PC3 Neo cells (Fig. 3D) and these
results clearly suggest that the EMT-type characteristics of PC3
PDGF-D cells are consistent with the signatures of stem cells or
cancer stem-like cells.
Notch signaling has been shown to play important roles in
pluripotency and self-renewal capacity of both embryonic and
adult stem cells [35,36]. The results from our microarray data
showed that mRNA levels of Notch, Notch ligands, delta-like,
Jagged as well as Notch downstream targets such as Hes and Hey
were significantly higher in PC3 PDGF-D cells compared to PC3
Neo cells (Table S2). Real time RT-PCR showed 2 to 350-fold
increase in mRNA levels of Notch signaling genes (Fig. 3E), which
were further confirmed by Western blot analysis as shown in
Fig. 3F. Likewise, we also found significantly increased level of
Notch1 expression in ARCaPM cells compared to ARCaPE cells
(Fig. 1B, right panel).
MiR-200b and miR-200c expression linked cancer stem
cell signatures with EMT phenotype
In our previous studies, we found significant down-regulation of
miR-200 family in PC3 PDGF-D cells with EMT phenotype [28],
which was consistent with our miRNA microarray data (Table S3).
To reveal whether expressions of miR-200 family are associated
with stem cell signatures, PC3 PDGF-D cells were transfected with
miR-200a, miR-200b and miR-200c. We found that transfection
of miR-200b and miR-200c induced reversal of EMT to MET
phenotype (Fig. 4A). More importantly, re-expression of miR-
200b and miR-200c significantly inhibited the prostasphere-
forming ability of PC3 PDGF-D cells (Fig. 4B). Moreover, the
size of prostaspheres was also reduced in PC3 PDGF-D cells
transfected with miR-200b and miR-200c compared to transfec-
tion with control miRNA (Fig. S2A and S2B). However,
transfection of PC3 PDGF-D cells with miR-200a had no effect
on prostasphere-forming ability but increased the size of prosta-
spheres compared to control (Fig. 4B, Fig. S2A and Fig. S2B).
Figure 2. Prostaspheres were increased in cells having EMT phenotype. (A) Prostaspheres from PC3 Neo and PC3 PDGF-D cells were
photographed and shown (bar, 100 mm). (B) The numbers of prostaspheres were counted under microscope. (C) Prostaspheres were photographed
and the size of prostaspheres in diameter was measured using software image analysis program Scion Image. (D) The prostaspheres (P1) were
collected and re-plated at a density of one cell per well in 96-well plate with ultra low attachment. After 12 days of incubation, the numbers of
prostaspheres (P2) were counted under a phase contrast microscope. (E) The numbers of prostaspheres from ARCaPE and ARCaPM cells were counted
under microscope. (F) Prostaspheres from ARCaPE and ARCaPM cells were photographed and shown (bar, 100 mm). **, p,0.01 compared to Neo or
ARCaPE cells (Neo: PC3 Neo cells, PDGF-D: PC3 PDGF-D cells).
doi:10.1371/journal.pone.0012445.g002
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200a inhibited self-renewal of PC3 PDGF-D cells by controlling
target gene expressions of miR-200b and miR-200c. Thus, we
assessed the expression of the putative targets of miR-200b and
miR-200c such as Notch1, Bmi1 and lin28B in PC3 PDGF-D cells
transfected with miR-200 family because miR-200b and miR-200c
have three or one putative binding sites in the 39UTR of Lin28B,
Bmi1 mRNA (Fig. S3) and Notch1 mRNA. The miR-200b and
miR-200c transfection dramatically reduced the expression of
Notch1 and lin28B, but had no effect on the expression of Bmi1
(Fig. 4C). The expression of ZEB1 was found to be down-regulated
by forced expression of miR-200b and miR-200c (Fig. 4C), which
was consistent with the reversal of EMT phenotype (Fig 4A). We
also found that miR-200c expression was repressed in ARCaPM
cells compared with ARCaPE cells (Fig. 4D). Moreover, re-
expression of miR-200c in ARCaPM cells by transfection with pre-
miR-200c precursors markedly reduced the prostasphere-forming
capacity compared to transfection with control miRNA (Fig. 4E).
These results were consistent with down-regulation of Notch1
expression and reversal of EMT phenotype as characterized by
increased expression of E-cadherin and decreased expression of
ZEB1 as well as cellular morphology change in ARCaPM cells
transfected with pre-miR-200c precursors (Fig. 4F and Fig. 4G).
Down-regulation of Notch1 by miR-200 was partially
responsible for the inhibition of colonogenic and
prostasphere-forming ability of PC3 PDGF-D cells
The miR-200b and miR-200c has one binding sites inthe 39UTR
of Notch1 (Fig. 5A). To determine whether Notch1 is the direct
target of miR-200b and miR-200c, we analyzed the activity of 39
UTR of Notch1 in PC3 Neo and PC3 PDGF-D cells transfected
with 39UTR of Notch1 luciferase plasmid as well as PC3 PDGF-D
Figure 3. Gene expression profiling of stem cell markers in PC3 PDGF-D cells with EMT signatures. (A) The expression of genes at the
mRNA levels for Oct4, Nanog, Sox family genes and Lin28B in PC3 Neo and PC3 PDGF-D cells were determined by using real time RT-PCR. (B) The
results from Western blot showed that the expressions of Oct4 Sox2, Nanog, Stat3 and Lin28B were significantly increased in PC3 PDGF-D cells. (C)
Real time RT-PCR was used to quantify the mRNA expression of EED, EZH2 and Suz12a. Relative mRNA levels were normalized to GAPDH. (D) The
results from Western blot showed that the expression of EZH2 was significantly increased in PC3 PDGF-D cells. (E) The mRNA levels of Notch signaling
factors in PC3 Neo and PC3 PDGF-D cells were determined by using real time RT-PCR. (F) The results from Western blot showed that the expressions
of Notch and Notch ligands were significantly increased in PC3 PDGF-D cells. GAPDH was used for protein loading control. (N: PC3 Neo cells, D: PC3
PDGF-D cells,p10: passage 10).
doi:10.1371/journal.pone.0012445.g003
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miR-200b or miR-200c. We found that the activity of 39UTR of
Notch1 luciferase was significantly increased in PC3 PDGF-D cells
compared with PC3 Neo cells due to lower levels of miR-200b and
miR-200c in PC3 PDGF-D cells. Moreover, re-expression of miR-
200b or miR-200c dramatically reduced the activity of 39UTR of
Notch1luciferaseinPC3 PDGF-Dcells,whilere-expression ofmiR-
200a with one base of seed sequence different from miR-200b and
miR-200c had no effects on the activity of 39UTR of Notch1
luciferase (Fig. 5B). These results suggest that the miR-200b and
miR-200c regulate the Notch1 expression by binding to 39UTR of
Notch1 mRNA. Todetermine whether Notch1played animportant
role in maintaining the stem cells, we treated the PC3 PDGF-D cells
with DAPT, a c-secretase inhibitor that inhibits the activation of
Notch. Full length Notch1 is usually very low due to its cleavage by
many enzymes in these cells; however, we found that the expression
of full length Notch1 was slightly more in c-secretase treated cells.
We also found that DAPT significantly reduced clonogenic ability of
Figure 4. MiR-200 repressed the self-renewal capacity by regulating Notch1 and Lin28B expression. PC3 PDGF-D cells were transfected
with pre-miR-200. 3 days after transfection, cells were split and transfected repeatedly with pre-miR-200 every 3–4 days for 14 days. (A) Photographs
of cells are shown: transfection of PC3 PDGF-D cells with pre-miR-200 for 14 days, miR-200b and miR-200c reversed EMT cells to MET cell morphology.
(B) The cells were collected for generation of prostaspheres after 14-day transfection with pre-miR-200. MiR-200b and miR-200c reduced the number
of prostaspheres. (C) Western Blot showing that Notch1, Lin28B and ZEB1 expressions were down-regulated in PC3 PDGF-D cells transfected with
miR-200b and miR-200c. (D) The level of miR-200c significantly decreased in ARCaPM by using real time RT-PCR. (E) Transfection of pre-miR-200c after
6 days reduced the prostasphere-forming ability in ARCaPM cells (Bar:100 mm). (F) Western blot showed that re-expression of miR-200c by transfection
of pre-miR-200c increased the E-cadherin expression and repressed expression of ZEB1 and Notch1 in ARCaPM cells, which consistent with the change
from mesenchymal to epithelial cell morphology (G). *, p,0.05 compared to control; **, p,0.01 compared to control. (Con: control, 200a: pre-miR-
200a, 200b: pre-miR-200b, 200c: pre-miR-200c, E-cad: E-cadherin).
doi:10.1371/journal.pone.0012445.g004
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Western blot data showing that DAPT treatment inhibited active
form of Notch1 (Fig. 5C, lower panel). Moreover, transfection of
Notch1 siRNA dramatically repressed the prostasphere-forming
ability of PC3 PDGF-D cells (Fig. 5D and 5E), which was consistent
with down-regulation of Notch1 protein expression (Fig. 5F). These
results suggest that miR-200 mediated down-regulation of Notch1
was partially responsible for self-renewal capacity and colonogenic
growth of EMT-like cells having stem cell features.
Lin28B inhibited production of let-7, regulating self-
renewal by controlling the expression of Sox2, Nanog
and Oct4
Our results presented above showed that the miR-200b and
miR-200c inhibited lin28B expression (Fig. 4C), which is known to
bind to primary let-7 and pre-let-7 RNA and inhibits the
accumulation of mature let-7 miRNA [19]. The results from our
miRNA microarray data showed that all the members of let-7
family were significantly reduced in PC3 PDGF-D cells (Table S3).
These results were confirmed by real time RT-PCR assay (Fig. 6A).
Knock-down of Lin28B by siRNA strongly increased mature let-7
expressions (Fig. 6B); suggesting lin28B regulated mature let-7
expression in PC3 PDGF-D cells. It is well known that let-7 family
plays a critical role in regulating self-renewal in embryonic stem
cells and breast cancer stem-like cells [18,37]. To determine
whether let-7 could control self-renewal of PC3 PDGF-D cells, we
performed the sphere-forming assay. Re-expression of selected let-
7 family such as let-7a, let-7b, let-7d or combination of let-7a, let-
7b and let-7d markedly inhibited prostasphere-forming capability
(Fig. 6C and 6D) and simultaneously reduced the size of
prostaspheres (Fig. 6C, S4A and S4B). Since Lin28B inhibits
accumulation of mature let-7 by binding to pre-let-7 RNA and
thereby blocking the processing of pre-let-7 RNA, PC3 PDGF-D
cells with high level of Lin28B were co-transfected with pre-let-7
and Lin28B siRNA. We found that prostasphere numbers from
cells co-transfected with pre-let-7 and Lin28B siRNA were less
than that of transfection with pre-let-7 alone (Fig. 6D); however,
except for let-7d, there was no difference in prostasphere size
between pre-let-7 alone and co-transfection with pre-let-7 and
Lin28B siRNA (Fig. 6C, S4A and S4B). These results were
consistent with the data from Western blot analysis showing that
the re-expression of let-7 significantly inhibited Sox2 and Nanog
expression in PC3 PDGF-D cells by transfection of pre-let-7a, pre-
let-7b or co-transfection of pre-let-7a, pre-let-7b or pre-let-7d with
Lin28B siRNA. Transfection of pre-let-7d alone was able to inhibit
the expression of Lin28B and Oct4 but had marginal effects on
Sox2 and Nanog expression (Fig. 6E).
Sox2, Nanog, Oct4 and Lin28B were required for self-
renewal of PC3 PDGF-D cells
We have shown that let-7 family regulated self-renewal and
inhibited Sox2, Nanog, Oct4 and Lin28B expression in PC3
Figure 5. Inactivation of Notch1 repressed the colonogenic and prostasphere-forming capacity. (A) Conserved, predicted binding sites
for the seed sequences of miR-200b and mir-200c in the 39UTR of Notch1 mRNA. (B) MiR-200b and miR-200c inhibited the Notch1 39UTR luciferase
activity. **, p,0.01 compared to Neo control cells; #,p ,0.01 compared to PDGF-D control cells. (C) DAPT treatment, a c-secretase inhibitor, reduced
the clonogenic ability in PC3 PDGF-D cells (upper panel).Western Blot showing that DAPT treatment reduced active form of Notch1 in dose-
dependent manner (lower panel). (D) and (E) showing that transfection of Notch1 siRNA after 9 days repressed the prostasphere-forming capacity in
PC3 PDGF-D cells (Bar:100 mm), which is consistent with downregulation of Notch1 expression (F). **, p,0.01 compared to control. (Neo: PC3 Neo
cells, PDGF-D: PC3 PDGF-D cells, Con: control, 200a: pre-miR-200a, 200b: pre-miR-200b, 200c: pre-miR-200c).
doi:10.1371/journal.pone.0012445.g005
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mechanistic link of these molecules (Sox2, Nanog, Oct4 and
Lin28B) with the self-renewal capacity of PC3 PDGF-D cells, we
knocked down the expression of Sox2, Nanog, Oct4 and Lin28B
by siRNA transfection using Sox2, Nanog, Oct4 and Lin28B
specific siRNA. We found that knock-down of Sox2, Nanog, Oct4
and Lin28B significantly repressed prostasphere-forming ability
(Fig. 7A). Furthermore, PC3 PDGF-D cells transfected with Sox2,
Nanog, Oct4 and Lin28B siRNA showed significantly increased
numbers of prostaspheres in smaller size (30–50 mm) compared to
that transfected with control siRNA concomitant with decreased
numbers of prostaspheres with .50 mm in diameter (Fig. 7B).
These results were consistent with protein expression results as
shown in Fig. 7C, suggesting that Sox2, Nanog, Oct4 and Lin28B
are required for self-renewal of PC3 PDGF-D cells.
The cells with EMT phenotype promoted tumorigenicity
In our previous studies, we showed that the tumors from PC3
PDGF-D cells grew much faster compared to that from PC3 Neo
cells in an animal model of experimental bone metastasis [26]. For
our current animal model studies, PC3 Neo and PC3 PDGF-D
cells were injected subcutaneously into the right and left flanks of
each mouse and compared tumor growth rate between PC3 Neo
and PC3 PDGF-D cells. We found that the volume of tumors
induced by PC3 PDGF-D cells was significantly larger than that of
PC3 Neo cells (Fig. 8A). To reveal whether tumor cells in vivo have
the signatures in the expression of genes similar to in vitro
experiments, we assessed the expression of selected genes related to
EMT and stem cell markers. We found down-regulation of E-
cadherin and up-regulation of mesenchymal markers such as
vimentin and ZEB1 in tumor tissues derived from PC3 PDGF-D
cells compared with PC3 Neo control cells. Concomitantly,
Lin28B, Sox2, Nanog and Oct4 as well as Notch1 expression
was also significantly increased in tumors derived from PC3
PDGF-D cells, which was consistent with increased PDGF-D
expression (Fig. 8B). Immunohistochemical analysis showed that
the tumors derived from PC3 PDGF-D cells contained much
intense staining for vimentin and Notch1 and less intense staining
for E-cadherin (Fig. 8C). These results suggest that the cells with
EMT phenotype promoted tumorigenicity in vivo.
Figure 6. Lin28B-mediated repression of let-7 was partially responsible for regulating self-renewal in PC3 PDGF-D cells. (A) The levels
for let-7 family in PC3 Neo and PC3 PDGF-D cells were determined by using real time RT-PCR. (B) Real time RT-PCR was used to quantify the
expression of let-7 in PC3 PDGF-D cells transfected with Lin28B siRNA for 3 days. (C) Photomicrographs showing prostaspheres generated from PC3
PDGF-D cells transfected with pre-let-7 or combination of pre-let-7 and Lin28B siRNA 14 days after transfection (bar:100 mm). (D) The cells were
collected for prostasphere-forming assay after 14-day transfection. Let-7a, let-7b, let-7d and combination of Let-7a, let-7b, let-7d as well as co-
transfection with let-7 and Lin28B siRNA decreased the number of prostaspheres. (E) The results from Western blot showed the expression of Lin28B,
Sox2, Nanog, and Oct4 in PC3 PDGF-D cells transfected with pre-let-7 or co-transfected with pre-let-7 and Lin28B siRNA after 9-day transfection. *,
p,0.05 compared to control; **, p,0.01 compared to control. (Con: control, a: pre-let-7a, abd: combination of pre-let-7a, pre-let-7a, pre-let-7d, al:
combination of pre-let-7a and Lin28B siRNA, Lin28B-si: Lin28B siRNA, Neo: PC3 Neo cells, PDGF-D: PC3 PDGF-D cells).
doi:10.1371/journal.pone.0012445.g006
Stem Cell Feature in EMT Cells
PLoS ONE | www.plosone.org 8 August 2010 | Volume 5 | Issue 8 | e12445Taken together, EMT cells such as PC3 PDGF-D and
ARCaPM cells shared stem-like cell signatures characterized by
increased colonogenic and prostasphere-forming capacity. The
miR-200, especially miR-200b and miR-200c were identified to be
mechanically linked with EMT phenotype and stem cell signatures
in these cells via regulation of Notch1 and/or Lin28B expression.
Lin28B inhibited accumulation of mature let-7, which resulted in
the increased expression of Sox2, Nanog and Oct4 (Fig. 8D),
leading to increased self-renewal and tumor growth. Thus, miR-
200b and miR-200c appear to play a central role in linking EMT
with stem cell features in prostate cancer progression.
Discussion
Epithelial to mesenchymal transition is a physiological process
during embryonic development and functions in adults to promote
organ morphogenesis and tissue regeneration as well as wound
healing. Emerging evidence suggest that the acquisition of EMT is
strongly associated with cancer cell invasion and tumor metastasis.
Recently, studies have shown that cells with EMT phenotype
share characteristics that are consistent with the signatures of
cancer stem-like cells, which are associated with tumor recurrence
and drug resistant phenotype and contribute to the demise of
patients diagnosed with cancers [12,22,38]. In the current study,
we found that over-expression of PDGF-D in PC3 cells induced
cellular morphological changes that were consistent with the
acquisition of EMT phenotype as characterized by the loss of
expression of epithelial markers and the gain or increased
expression of mesenchymal markers. More importantly, PC3
PDGF-D cells displayed an increased clonogenic and prosta-
sphere-forming capacity, the characteristics that are known to be
associated with cancer stem-like cell characteristics. ARCaPM cells
were derived from ARCaP cells showing mesenchymal morphol-
ogy and increased expression of mesenchymal markers such as
ZEB1 and vimentin as well as decreased expression of epithelial
markers such as E-cadherin. Interestingly, ARCaPM cells also
displayed stem-like cell phenotype characterized by increased
clonogenic and prostasphere-forming capacity compared with
ARCaPE cells having epithelial phenotype. Our results suggest
that EMT-type cells show stem-like cells or cancer stem-like cell
characteristics.
It is well known that co-expression of Sox2, Nanog, Oct4 and
Lin28 or Oct4, Sox2, Klf4 and c-myc in human or mouse somatic
cells can reprogram these somatic cells into pluripotent embryonic
stem-like cells [4,5,39]. These results are consistent with data from
Dr. Ben-porath, et al. who demonstrated that histologically poorly
differentiated tumors showed preferential over-expression of
Nanog, Oct4, Sox2 and c-Myc genes that are normally enriched
in embryonic stem cells (ES cells). Moreover, they also found that
activation targets of Nanog, Oct4, Sox2 and c-Myc were more
frequently over-expressed concomitant with repression of poly-
comb-regulated genes in poorly differentiated tumors than in well-
differentiated tumors [7]. However, high-grade tumors with ES
signatures failed to demonstrate CD44
high/CD24
low population of
cells in these tumors [7], suggesting the complexity of stem cell
characteristics. In our study, we found that the expressions of
Sox2, Nanog, Oct4 and Lin28B were dramatically up-regulated in
PC3 PDGF-D cells. More importantly, knock-down of Sox2,
Nanog, Oct4 and Lin28B by siRNA transfection repressed
prostasphere-forming capacity of PC3 PDGF-D cells. Moreover,
we also found enhanced expression of Stat3, Sall2, Sall4, Zic2 and
Zic3, downstream targets of Nanog, Oct4 and Sox2, and up-
regulation of EZH2, Suz12 and EED (which consisted polycomb
repressor complex 2) in PC3 PDGF-D cells. Polycomb repressor
complex 2 occupies developmental genes in ES cells to maintain
pluripotency of ES cells. Target genes of polycomb repressor
complex are known to be repressed in ES cells, and activated
during the ES cell differentiation, and are regulated by Nanog,
Oct4 and Sox2 [32,33]. Taken together, PC3 PDGF-D cells with
EMT signatures showed stem-like cell characteristics through
over-expression of Nanog, Oct4 and Sox2, Lin28B and activation
of polycomb repressor complex 2.
The miR-200 family plays a critical role in mediating EMT
phenotype induced by various factors including PDGF-D
Figure 7. Sox2, Nanog, Oct4 and Lin28B regulated Prostasphere-forming ability of PC3 PDGF-D cells. (A) Single cell suspensions of PC3
PDGF-D transfected with Sox2, Nanog, Oct4 and Lin28B siRNA and incubated for 24 h were plated on ultra low adherent wells of 6-well plate at 2000
cells/well. After 3 days, the numbers of prostaspheres were counted under microscope. Transfection of Sox2, Nanog, Oct4 or Lin28B siRNA reduced
the prostasphere-forming capacity (B) Prostaspheres were photographed and the size of prostaspheres in diameter was measured using software
image analysis program Scion Image. (C). Western blot analysis showed that levels of Sox2, Nanog, Oct4 and Lin28B in PC3 PDGF-D cells transfected
with Sox2, Nanog, Oct4 and Lin28B siRNA compared with transfection with control siRNA (*, p ,0.05, **, p,0.01 compared to control, Con: control).
doi:10.1371/journal.pone.0012445.g007
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contribute to the generation of cancer stem-like cell characteristics
in ARCaPM and PC3 PDGF-D cells by regulating the expression of
Nanog, Oct4 and Sox2, Lin28B and other stem cell-associated
makers, we have searched targets of miR-200 family in www.
microRNA.org.We foundthat miR-200b and miR-200chavethree
binding sites at the 39UTR of Lin28B mRNA, one in Notch1, Sox2
andBmi1.Interestingly,miR-200b andmiR-200cweresignificantly
decreased in PC3PDGF-Dcells and miR-200c was down-regulated
in ARCaPM cells. Therefore, we analyzed the expression of Lin28B,
Notch1 and Bmi1, and performed the sphere-forming assay using
ARCaPM and PC3 PDGF-D cells transfected with miR-200. We
found that re-expression of miR-200b and miR-200c dramatically
reduced the sphere-forming ability concomitant with decreased
expression of Lin28B and Notch1 in PC3 PDGF-D cells. The miR-
200c also dramatically reduced the sphere-forming ability concom-
itant with decreased expression of Notch1 in ARCaPM cells
compared to its isogenic ARCaPE cells.
Lin28B, a Lin28 homolog, was significantly repressed by re-
expression of miR-200b and miR-200c in our cell model. It has
been shown to selectively block the processing of pri-let-7 miRNAs
in embryonic cells, resulting in decreased mature let-7 [19]. In the
present study, we found that Lin28B was significantly increased
and let-7 family was strongly repressed in PC3 PDGF-D cells.
Transfection of Lin28B siRNA enhanced let-7 expression,
suggesting increased Lin28B was responsible for the loss of let-7
in PC3 PDGF-D cells. The let-7 was known to promote
differentiation of embryonic cells, reduced expression of let-7
was associated with increased self-renewal ability in breast cancer
cells [18]. Thus, we hypothesized that let-7 could regulate self-
renewal by regulating Nanog, Oct4, Sox2 and Lin28B expression
in PC3 PDGF-D cells. In order to prove our hypothesis, PC3
PDGF-D cells were transfected with let-7, and we found that let-7a
and let-7b could reduce the sphere-forming capacity concomitant
with decreased expression of Sox2 and Nanog, These results were
consistent with the data showing that let-7 significantly inhibited
Figure 8. The cells with EMT phenotype promoted tumor growth. (A) Tumor growth curve showing that over-expression of PDGF-D could
promote tumor growth in SCID mice much faster than PC3 Neo cells. (B) Western blot analysis of tumor lysates showing the expression of EMT and
stem cell makers. (C) H&E evaluation of the tumors from both the groups showed high grade carcinoma associated with tumor apoptosis and
necrosis. The results from the immunostaining showed much intense staining for vimentin and Notch1 and less intense staining for E-cadherin. (D)
Regulatory model showing mechanistic link between EMT and stem cells: EMT induced by different factors characterized by increased expression of
ZEB1, which causes loss of miR-200 family. Loss of miR-200b and miR-200c lead to increased ZEB1, Notch1 and Lin28B expression, resulting in
decreased expression of let-7. Downregulation of let-7 leads to the up-regulation of Sox2, Nanog and Oct4, which together with Notch1 and Lin28B
contribute to stem cell signatures. (*, p ,0.05, **, p,0.01 compared to PC3 Neo, E-cad: E-cadherin).
doi:10.1371/journal.pone.0012445.g008
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[42].
In summary, the findings reported in this study showed, for the
first time, that ARCaPM and PC3 PDGF-D cells having EMT
phenotype shared cellular and molecular characteristics of stem
cells or cancer stem-like cells. Moreover, miR-200 and let-7 played
a critical role in linking EMT phenotype with stem cell signatures
by regulating the expression of Lin28B and Notch1. Therefore, we
believe that these models would be useful in screening drug
libraries for finding newer agents that could be useful in selective
killing of EMT-type or cancer stem-like cells in prostate cancer in
the future consistent with a similar approach that showed a great
success in breast cancer [43]. Interestingly, recent studies have
shown that some natural agents could up-regulate miR-200 and
reverse the EMT phenotype [44,45]. Thus, in future studies we
will use these natural agents to eliminate the stem-like cells by
reversing EMT phenotypic cells to MET phenotype for assessing
whether natural agents could be useful for the prevention of
prostate cancer recurrence and metastasis. We firmly believe that
strategies by which one could either reverse the EMT to MET
phenotype or could selectively kill EMT-phenotypic cells or cancer
stem-like cells would become a novel approach for the prevention
of tumor progression and/or treatment of CRPC and its
metastasis for which newer therapies are urgently needed.
Materials and Methods
Ethics Statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. Any
animal found unhealthy or sick were promptly euthanized. The
protocol was approved by the Committee on the Ethics of Animal
Experiments of Wayne State University institutional Users Animal
Care Committee (Permit Number: A-10-03-08).
Cell lines and culture condition
Generation of stable cell lines over-expressing PDGF-D was
accomplished by transfection of PC3 cells with the corresponding
empty vector pcDNA3 Neo or pcDNA3-PDGF-D:His as
previously described [31] and referred to as PC3 Neo, or PC3
PDGF-D cells, respectively throughout this manuscript. The PC3
Neo or PC3 PDGF-D cell lines were cultured in RPMI 1640
medium with 2 mmol/L glutamine, 25 mmol/L Hepes (Invitro-
gen, Carlsbad, CA) supplemented with 5% fetal bovine serum
(FBS), 50 units/ml Penicillin, and 50 mg/ml Streptomycin.
ARCaPE and ARCaPM cells were purchased from Novicure
Biotechnology (Birmingham, AL). ARCaPE and ARCaPM were
established from bone tumor tissue derived from ARCaP cells.
ARCaPE with cobblestone morphology expressed higher E-
cadherin and cytokeritin 18, 19, which were associated with
typical epithelial cell characters, and concomitant with lower level
of vimentin expression. In contract, ARCaPM with spindle-shape
fibrobastic morphology expressed more genes associated with
mesenchymal markers such as increased vimentin and N-
cadherin expression, and these cells also acquired drug-resistant
phenotype [46]. These cells were cultured in Prostate Epithelial
Cell Medium (MCaP) supplied by Novicure Biotechnology, and
the medium was supplemented with 5% fetal bovine serum (FBS),
50 units/ml Penicillin, and 50 mg/ml Streptomycin. All cells were
maintained in a 5% CO2-humidified atmosphere at 37uC, and
genotypically characterized to support the authenticity of these
cells, which was consistent with its origin.
Research reagents and antibodies
Antibodies against slug, Oct4, Sox2, Nanog and Lin28B were
purchased from Cell Signaling Technology (Beverly, MA).
Antibody against EZH2 was purchased from BD Biosciences
(Bedford, MA). Antibody to vimentin was acquired from Abcam
(Cambridge MA). Antibodies against ZEB1, ZEB2, Stat3, E-
cadherin, jagged2, delta1, delta3, delta4, Notch1, Notch2, and
Notch3 were obtained from Santa Cruz (Santa Cruz, CA). Goat
anti-rabbit IgG (H + L)-HRP conjugate and goat anti-mouse IgG
(H + L)-HRP conjugate were obtained from Bio-Rad (Reinach,
BL,). Antibody to glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) was purchased from Affinity BioReagents (Golden,
CO). DAPT (N-[N-(3,5-Difluorophenacetyl-L-alanyl)]-S-phenyl-
glycine t-Butyl Ester) was purchased from EMB Bioscience (San
Diego, California).
Clonogenic assay
PC3 Neo, PC3 PDGF-D, ARCaPE and ARCaPM cells were
collected after trypsinization, and re-suspended in the complete
medium. Single cell suspensions were plated in regular 10 cm in
diameter Petri dishes at the clonal density of 1,000 cells per dish.
After 2–3 weeks of culture, colonies were fixed with 4%
paraformaldehyde for 10 min, stained with crystal violet for
additional 10 min, and washed with 1X PBS. The colonies were
photographed. The colony numbers were counted using software
image analysis program Scion Image downloaded from NIH
website (http://www.scioncorp.com). Particle Analysis program
was used for counting the colony numbers. Data was presented as
relative colony number of PC3 Neo or ARCaPE designated as unit
value of one.
Soft agar assay
PC3 Neo and PC3 PDGF-D cells were harvested and
suspended in culture medium. To make the bottom layer, 1 ml
of 0.5% agarose (Invitrogen) was added to 6-well plates, and
allowed to gel at room temperature. To prepare the top layer
(0.25% agarose), 500 ı `l of 0.5% agarose was mixed with 500 ı `l cell
suspension containing the 5000 cells. This mixture were overlaid
above the bottom layer and allowed to solidify at room
temperature. An additional 2 ml of culture medium was added
after solidification to the top layer, and cells were incubated for 3
weeks at 37uC. After three weeks of growth, the colonies were
photographed (40 X). The colony numbers were counted under a
phase contrast microscope (40 X). Data was presented as colony
numbers per field.
Self-renewal assay
Single cell suspensions of PC3 Neo, PC3 PDGF-D, ARCaPE,
ARCaPM and PC3 PDGF-D cells transfected with Sox2, Nanog,
Oct4, Lin28B or control siRNA as well as miR-200 and let-7, were
plated on ultra low adherent wells of 6-well plate (Corning, Lowell,
MA) at 1000 or 2000 cells/well in DMEM/F12 (Invitrogen)
supplemented with B27 and N2 (Invitrogen). Single cell status was
confirmed under microscope. Fresh medium was added every 3–4
days. After 3 or 6 days, spheres termed here as ‘‘prostaspheres’’
(P1) numbers were counted under microscope and the proportion
of sphere-generating cells was calculated by dividing the number
of cells seeded by the number of prostaspheres. Prostaspheres were
photographed and the size of the prostaspheres in diameter was
measured using software image analysis program Scion Image
downloaded from NIH website. To confirm that prostaspheres
were the progeny of individual cells rather than the aggregation of
the multiple cells, the prostaspheres (P1) were collected by
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(Sigma) and the cells were plated at one cell per well in 96-well
plate with ultra low attachment. Single cell status was confirmed
under microscope. After 12 days incubation, the prostasphere (P2)
numbers were counted under a phase contrast microscope.
Western blot analysis
Total cell lysates from different experiments were obtained by
lysing the cells in RIPA buffer containing 50 mM Tris–HCl,
150 mM NaCl, 1% NP-40, 0.1% SDS, 0.5% sodium deoxycho-
late, 2 mM sodium fluoride, 2 mM Na3VO42, 1 mM EDTA,
1 mM EGTA, and 1 X protease inhibitor cocktail. Western
blotting was performed as previously described [47].
siRNA, miRNA and transfection experiments
Cells were transfected with 100 nmol/L of Sox2, Nanog, Oct4,
Lin28B siRNA or control siRNA (Santa Cruz) as well as 20 nmol/
L of miR-200 or let-7 (Ambion, Austin, TX) using DharmaFECT3
siRNA transfection reagent (DHARMACON, Lafayette, CO).
After 3 days of transfection, cells were split and transfected
repeatedly with siRNA or miRNA every 3–4 days for indicated
times. After 24 h of incubation from last transfection, the cells
were collected after trypsinization and then re-suspended in
DMEM/F12 (Invitrogen) supplemented with B27 and N2
(Invitrogen). The single cell suspensions were plated on ultra low
adherent wells of 6-well plate (Corning) at 2000 cells/well for
generation of prostaspheres. In addition, the cell lysates from cells
transfected with siRNA or pre-miRNA were prepared for Western
blot analysis.
Luciferase activity assay
PC3 Neo and PC3 PDGF-D cells were seeded at a density of
6610
3 cells per well in 96-well plate and incubated for 24 h. The
cells were co-transfected with Notch1 39UTR luciferase plasmid
(Switch Gear Genomics, Menlo Park, CA) and pre-miR-200 using
DharmaFECT duo transfection reagent (DHARMACON, Lafay-
ette, CO). After 48 h of transfection, luciferase activity was assayed
using Steady–Glo Luciferase Assay System (Promega). The renilla
luciferase activity was used as a control for transfection efficiency.
Real-time RT-PCR
The total RNA was isolated using the Trizol reagent. Two
micrograms of RNA were transcribed into cDNA using High
Capacity RNA-to-cDNA Kit (Applied biosystems, Fostor, CA)
according to the manufacturer’s instruction. Real time PCR was
used to quantify mRNA expression by using SYBRH Green RT-
PCR Reagents (Applied biosystems). Sequences of primers were
shown in table S4. The relative amount of RNA was normalized to
the expression of GAPDH. For miRNA assay, the total RNA was
isolated and PCR was performed as previously described [28].
Microarray for gene profiling and miRNA microarray
Microarray and miRNA microarray as well as data analysis
were conducted following procedures documented under supple-
mentary materials and methods in text S1. All data is MIAME
compliant and that the raw data has been deposited in a MIAME
compliant database. GEO accession number is GSE22764.
Tumor growth in SCID mice
Male homozygous CB-17 SCID/SCID mice (8 weeks old) were
purchased from Taconic Farms (Germantown, NY). The mice
were maintained according to the Animal Care and Use
Guidelines approved by the NIH. Mice received Lab Diet 5021
(Purina Mills, Inc., Richmond, IN). After 1 week of acclimatiza-
tion, the mice were randomized into two groups (n=5) for our
study. PC3 Neo and PC3 PDGF-D cells were harvested and re-
suspended in serum-free RPMI medium. Cells (1610
5) in 100 ml
serum-free RPMI medium were injected subcutaneously into the
right and left flanks of each mouse. As soon as the majority of the
tumors began to enlarge (50–75 mm
3 volume, as determined by
caliper measurements, 15–20th day after cell injection), mice with
tumor take rate of 100% were carefully monitored and tumor
volume were calculated in each group by twice-weekly caliper
measurements. Comparison of growth kinetics between the PC3
Neo and PC3 PDGF-D cell line using this model system, the body
weight of mice in each group was also monitored. All mice were
euthanized 5 weeks later after the initiation of the experiment
because large tumors were formed in the PC3 PDGFD group of
mice, which required termination and their final body weight and
tumor volume was recorded.
On autopsy, the tumor was neatly excised free of any extraneous
adhering tissue. The tissue was rapidly frozen in liquid nitrogen,
and stored at 270uC and subsequently used for preparation of
protein extracts. Total protein was extracted from tumor tissues
and prepared for Western blot analysis. Randomly selected
harvested tumor tissue from each group of experimental mice
were homogenized using Dounce homogenizer (Kontes Co.,
Vineland, NJ) containing 0.3 ml of ice-cold RIPA buffer solution
with added protease inhibitors and 0.1 mM PMSF. The
suspension was centrifuged at 16,0006 ga t4 uC for 10 min.
The supernatant was collected and kept at 270uC until used for
Western blot analysis.
Immunohistochemistry
Formalin-fixed tumor tissue sections were evaluated for tumor
cell morphology, mitotic rate, growth pattern, necrosis, cystic
change, and inflammatory cellular response. Immunohistochem-
ical studies were performed after staining with specific primary
antibodies against E-cadherin, Vimentin and Notch1, followed by
3,39-diaminobenzidine (DAB). Sections were visualized under an
Olympus microscope (Olympus, Japan) and images were captured
with an attached camera linked to a computer.
Data analysis
Experiments (in vitro) presented in the figures are representative
of three or more independent repetitions. The data are presented
as the mean values 6 SD. Comparisons between groups were
evaluated by a two-tailed student’s t test. Values of p,0.05 were
considered statistically significant.
Supporting Information
Text S1 Supplementary materials and methods.
Found at: doi:10.1371/journal.pone.0012445.s001 (0.04 MB
DOC)
Figure S1 PDGF-D levels in PC3 Neo and PC3 PDGF-D cells.
Western Blot showed full length and active form of PDGF-D from
PC3 PDGF-D cell lysates (A) and conditioned medium (B).
Found at: doi:10.1371/journal.pone.0012445.s002 (1.63 MB TIF)
Figure S2 MiR-200b and miR-200c inhibited prostasphere-
forming ability of PC3 PDGF-D cells. PC3 PDGF-D cells were
transfected with pre-miR-200. 3 days after transfection, cells were
split and transfected repeatedly with pre-miR-200 every 3–4 days
for 14 days. (A) MiR-200b and miR-200c increased the numbers
of prostaspheres with ,100 mm in diameter and decreased the
numbers of prostaspheres with .100 mm in diameter. (B) MiR-
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prostaspheres.
Found at: doi:10.1371/journal.pone.0012445.s003 (1.66 MB TIF)
Figure S3 Binding sites of miR-200b and miR-200c in 39UTR
of Lin28B or Bmi1 mRNA. Conserved, predicted binding sites for
the seed sequences of miR-200b and mir-200c in the 39UTR of
Lin28B or Bmi1 mRNA were shown.
Found at: doi:10.1371/journal.pone.0012445.s004 (3.36 MB TIF)
Figure S4 Let-7 regulated the self-renewal of PC3 PDGF-D. (A)
Transfection of pre-let-7 or combination of pre-let-7 and Lin28B
siRNA reduced the size of prostaspheres. (B) Transfection of pre-
let-7 or combination of pre-let-7 and Lin28B siRNA increased the
numbers of prostaspheres with smaller size (30–50 mm) and
reduced the number of prostaspheres with bigger size
(.100 mm) compared to transfection with control. **, p,0.01
compared to control (Con: control, a: pre-let-7a, abd: combination
of pre-let-7a, pre-let-7a, pre-let-7d, al: combination of pre-let-7a
and Lin28B siRNA, Lin28B-si: Lin28B siRNA).
Found at: doi:10.1371/journal.pone.0012445.s005 (1.75 MB TIF)
Table S1 Fold change in EMT-associated genes induced by
over-expression of PDGF-D in PC3 cells.
Found at: doi:10.1371/journal.pone.0012445.s006 (0.03 MB
DOC)
Table S2 Fold change in the expression of genes associated with
stem-like cells in PDGF-D over-expressing PC3 cells compared to
PC3 Neo cells.
Found at: doi:10.1371/journal.pone.0012445.s007 (0.04 MB
DOC)
Table S3 The levels of miR-200 and let-7 family in PC3 Neo
and PC3 PDGF-D cells.
Found at: doi:10.1371/journal.pone.0012445.s008 (0.02 MB
DOC)
Table S4 Primer sequences used in real time PCR.
Found at: doi:10.1371/journal.pone.0012445.s009 (0.04 MB
DOC)
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